Our in vitro data combined with the in vivo findings indicate a migratory and immunomodulatory role of CXCL10 in hyperoxia-induced neonatal lung injury and BPD, offering a possible target for pharmacological treatment or prevention. The gene discussed is CXCL10; the disease is bronchopulmonary dysplasia.